Den Broek Richard Van's Net Worth

$30.5 Million

Estimate Recalculated Jul 9, 2024 08:22AM EST

Who is Den Broek Richard Van?

Den Broek Richard Van has an estimated net worth of $30.5 Million. This is based on reported shares across multiple companies, which include Celldex Therapeutics, Inc., PhaseBio Pharmaceuticals Inc, Pulse Biosciences, Inc., SPECIAL DIVERSIFIED OPPORTUNITIES INC., RESPONSE GENETICS INC, and PHARMACYCLICS INC.

SEC CIK

Den Broek Richard Van's CIK is 0001431872

Past Insider Trading and Trends

2010 was Den Broek Richard Van's most active year for acquiring shares with 10 total transactions. Den Broek Richard Van's most active month to acquire stocks was the month of April. 2015 was Den Broek Richard Van's most active year for disposing of shares, totalling 30 transactions. Den Broek Richard Van's most active month to dispose stocks was the month of April. 2012 saw Den Broek Richard Van paying a total of $168,500.00 for 144,486 shares, this is the most they've acquired in one year. In 2015 Den Broek Richard Van cashed out on 130,132 shares for a total of $7,735,612.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Celldex Therapeutics, Inc. (CLDX) Snapshot price: $38.17

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.47%
10K
—
—
233.5K
Jun 8
Form 4
+325.00%
6.5K
—
—
8.5K
Jun 10
Form 4
∞
2K
—
—
2K
Dec 17
Form 3
—
0
—
—
0
No matching records found

PhaseBio Pharmaceuticals Inc (PHASQ) Snapshot price: $0.0002

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3.75K
—
—
0
May 19
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
Jun 3
Form 4
—
0
—
—
0
May 9
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Feb 27
No matching records found

Pulse Biosciences, Inc. (PLSE) Snapshot price: $8.7

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 19
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
Aug 6
Form 3
—
0
—
—
0
No matching records found

SPECIAL DIVERSIFIED OPPORTUNITIES INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.72%
2.5K
—
—
28.23K
Nov 22 - Jun 23
Form 4
-100.00%
-75.00K
$1.11
-$83,602.50
0
Dec 24
Form 4
-25.00%
-25.00K
$1.11
-$27,750.00
75K
Dec 23
Form 4
-28.52%
-39.90K
$1.13
-$45,087.00
100K
Dec 19
Form 4
-35.00%
-70.00K
$1.12
-$78,200.00
130K
Dec 17 - Dec 18
Form 4
+7.55%
2.5K
—
—
35.63K
May 15
Form 4
+8.16%
2.5K
—
—
33.13K
May 17
Form 4
+47.76%
9.9K
$1.88
$18,612.00
30.63K
Aug 23
Form 4
+13.71%
2.5K
—
—
20.73K
May 18
Form 4
+15.89%
2.5K
—
—
18.23K
May 12
Form 4
∞
15.73K
—
—
15.73K
Dec 31
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Mar 12
No matching records found

RESPONSE GENETICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 10
Form 4
—
0
—
—
0
Nov 20
Form 4
—
0
—
—
0
Jul 30
Form 4
+54.73%
100K
$1.50
$150,000.00
282.7K
Feb 2
Form 4
—
0
—
—
0
Oct 13
Form 4
—
0
—
—
0
Apr 12
Form 4
—
0
—
—
0
Dec 1
Form 3
—
0
—
—
0
No matching records found